Ekso Bionics Holdings, Inc. (EKSO) | AI Infrastructure Stock

Ekso Bionics Holdings, Inc.
EKSO
$15.90 (-21.4%)
Last update 01:32 PM UTC · Aug 24 · NASDAQ
#90 AI Infrastructure
Ekso Bionics Holdings, Inc.
EKSO
#90 in AI Infrastructure
AI Infrastructure Stock · NASDAQ · San Rafael, US
$15.90 (-21.4%)
Last update 01:32 PM UTC · Aug 24, 2026

Market

Market Overview

Market Cap
$38,571,651
Shares Outstanding
2,425,890
50-Day Moving Average
$17.54
200-Day Moving Average
$9.65
Average Volume (20 Days)
308,314
Beta (5Y)
0.82

Price History

Date OPEN HIGH LOW CLOSE VWAP VOLUME %CHG $CHG

About

Ekso Bionics Holdings, Inc. Company Overview

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) is a designer and manufacturer of wearable exoskeleton robotics products headquartered in San Rafael, California, operating EksoHealth (medical exoskeletons including EksoNR for neurorehabilitation and EksoUE for upper-extremity assistance) and EksoWorks (industrial exoskeletons) segments. The company has signed a non-binding term sheet to spin out Applied Digital's cloud business via a combination with EKSO to form ChronoScale (with EKSO shareholders to own ~3% of the combined company post-close), and recently priced a $5.85 million private placement. Ekso also signed an exclusive U.S. distribution agreement with MediTouch for the BalanceTutor rehabilitation system.

Stock Exchange NASDAQ
IPO Date 2014-01-15
Number of Employees 53
Headquarters San Rafael, California, US

Key Executives

News & Filings

Press Releases

No press releases found.

SEC Filings

Form Type Filed Accepted Source

Earnings Call Summaries

EKSO Frequently Asked Questions

The current stock price of Ekso Bionics Holdings, Inc. (EKSO) is $15.9 as of 01:32 PM UTC · Aug 24, 2026 . For live stock updates and company rankings, view our Bitcoin mining stocks by market cap table.

The latest news for Ekso Bionics Holdings, Inc. (EKSO) includes ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth published on May 6, 2026 . For more details and ongoing updates, visit the EKSO news section.